Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Research ArticleResearch

How Many Batches Are Needed for Process Validation under the New FDA Guidance?

Harry Yang
PDA Journal of Pharmaceutical Science and Technology January 2013, 67 (1) 53-62; DOI: https://doi.org/10.5731/pdajpst.2013.00902
Harry Yang
MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 67 no. 1 53-62
DOI 
https://doi.org/10.5731/pdajpst.2013.00902
PubMed 
23385564

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online February 5, 2013.

Copyright & Usage 
© PDA, Inc. 2013

Author Information

  1. Harry Yang
  1. MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878
  1. YangH{at}MedImmune.com
View Full Text

Cited By...

  • 7 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Bayesian assurance and sample size determination in the process validation life-cycle
    Paul Faya, John W. Seaman, James D. Stamey
    Journal of Biopharmaceutical Statistics 2017 27 1
  • A Statistical Approach to Determining Criticality of Residual Host Cell DNA
    Harry Yang, Ziping Wei, Mark Schenerman
    Journal of Biopharmaceutical Statistics 2015 25 2
  • Nonclinical Statistics for Pharmaceutical and Biotechnology Industries
    Helen Strickland, Stan Altan
    2016
  • The current state of Bayesian methods in nonclinical pharmaceutical statistics: Survey results and recommendations from the DIA/ASA‐BIOP Nonclinical Bayesian Working Group
    Paul Faya, Perceval Sondag, Steven Novick, Dwaine Banton, John W. Seaman, Jr, James D. Stamey, Bruno Boulanger
    Pharmaceutical Statistics 2021 20 2
  • Developing Solid Oral Dosage Forms
    D.Y. Peng, Y. Hu, S. Chatterjee, D. Zhou
    2017
  • Estimating Number of PPQ Batches: Various Approaches
    Naseem Ahmad Charoo
    Journal of Pharmaceutical Innovation 2018 13 2
  • Statistical Applications for Chemistry, Manufacturing and Controls (CMC) in the Pharmaceutical Industry
    Richard K. Burdick, David J. LeBlond, Lori B. Pfahler, Jorge Quiroz, Leslie Sidor, Kimberly Vukovinsky, Lanju Zhang
    2017
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 67 (1)
PDA Journal of Pharmaceutical Science and Technology
Vol. 67, Issue 1
January/February 2013
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
How Many Batches Are Needed for Process Validation under the New FDA Guidance?
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 18 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
How Many Batches Are Needed for Process Validation under the New FDA Guidance?
Harry Yang
PDA Journal of Pharmaceutical Science and Technology Jan 2013, 67 (1) 53-62; DOI: 10.5731/pdajpst.2013.00902

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
How Many Batches Are Needed for Process Validation under the New FDA Guidance?
Harry Yang
PDA Journal of Pharmaceutical Science and Technology Jan 2013, 67 (1) 53-62; DOI: 10.5731/pdajpst.2013.00902
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Number of Validation Batches
    • Examples
    • Discussion
    • Summary
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • A Bayesian Approach to Determination of F, D, and Z Values Used in Steam Sterilization Validation
  • Google Scholar

More in this TOC Section

  • Sensitization Assessment of Extractables and Leachables in Pharmaceuticals: ELSIE Database Analysis
  • Excipient and Packaging Material Impact on Glass and Polymer-Based Prefilled Syringe Functionality
  • Modeling the migration behaviour of extractables from mono- and multi-layer polyolefin films to mathematically predict the concentration of leachable impurities in pharmaceutical drug products. Part 1: Experimental details and modeling experimental results
Show more Research

Similar Articles

Keywords

  • Bayesian analysis
  • Life cycle approach
  • Process validation
  • Sample size
  • Validation batch

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2023 PDA Journal of Pharmaceutical Science and Technology ISSN: 1079-7440

Powered by HighWire